Stock listing
NASDAQ:ORKA Oruka Therapeutics, Inc. Stock
Home listing (NASDAQ) of Oruka Therapeutics, Inc.
Follow Oruka Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ORKA
$95.43 USD -1.44 (-1.5%)
Close on Nov 2, 2026
- Day range
- $94.29 – $99.83 USDNov 2, 2026
- Volume
- 654,335 sharesNov 2, 2026
- Market cap
- $6.32B USDAt the close on Nov 2, 2026 · price × 66.21M shares outstanding
- 52-week range
- $25.23 – $115.52 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $81.41M USDMedian day 798,075 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ORKA · Home | $95.43 USD | -1.44 (-1.5%) | 654,335 | $98.85 | $99.83 | $94.29 | $96.87 | Close on Nov 2, 2026 |
| Frankfurt:HQ1 | €80.50 EUR | +8.50 (+11.8%) | — | €80.50 | €80.50 | €80.50 | €72.00 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ORKA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $95.43 | -1.44 | -1.5% | $98.85 | $99.83 | $94.29 | 654,335 | |
| $96.87 | +0.22 | +0.2% | $94.87 | $97.60 | $94.75 | 633,810 | |
| $96.65 | +0.68 | +0.7% | $97.04 | $98.88 | $95.26 | 657,177 | |
| $95.97 | +0.16 | +0.2% | $95.26 | $98.45 | $94.17 | 798,075 | |
| $95.81 | +5.48 | +6.1% | $89.02 | $96.59 | $89.02 | 1,205,199 | |
| $90.33 | +10.18 | +12.7% | $81.98 | $93.42 | $81.98 | 1,942,729 | |
| $80.15 | -1.00 | -1.2% | $81.15 | $81.15 | $79.07 | 514,000 | |
| $81.15 | +1.23 | +1.5% | $79.06 | $82.15 | $78.36 | 589,900 | |
| $79.92 | +0.83 | +1.0% | $79.97 | $81.75 | $79.48 | 953,400 | |
| $79.09 | +4.61 | +6.2% | $74.42 | $79.90 | $74.42 | 787,700 | |
| $74.48 | +2.55 | +3.5% | $72.40 | $76.35 | $72.30 | 812,700 | |
| $71.93 | -1.94 | -2.6% | $73.75 | $74.26 | $70.50 | 1,388,200 | |
| $73.87 | -2.81 | -3.7% | $75.53 | $77.89 | $73.15 | 1,222,100 | |
| $76.68 | -1.51 | -1.9% | $77.37 | $78.57 | $75.41 | 685,300 | |
| $78.19 | -2.16 | -2.7% | $79.47 | $80.19 | $78.18 | 503,100 | |
| $80.35 | -1.76 | -2.1% | $81.81 | $82.95 | $79.43 | 547,900 | |
| $82.11 | +4.83 | +6.2% | $77.24 | $82.24 | $77.00 | 1,206,700 | |
| $77.28 | -2.22 | -2.8% | $78.47 | $80.19 | $75.83 | 1,225,000 | |
| $79.50 | -0.68 | -0.8% | $79.01 | $81.40 | $78.52 | 809,900 | |
| $80.18 | -4.20 | -5.0% | $84.94 | $84.94 | $77.78 | 1,122,000 | |
| $84.38 | -0.14 | -0.2% | $84.52 | $85.23 | $81.83 | 629,600 | |
| $84.52 | +1.10 | +1.3% | $84.81 | $86.00 | $83.33 | 581,500 | |
| $83.42 | +0.13 | +0.2% | $82.85 | $85.00 | $82.50 | 921,000 | |
| $83.29 | +1.14 | +1.4% | $83.33 | $86.51 | $82.27 | 1,535,600 | |
| $82.15 | -2.04 | -2.4% | $83.32 | $84.67 | $81.11 | 1,363,300 | |
| $84.19 | -0.27 | -0.3% | $83.94 | $85.95 | $83.22 | 923,300 | |
| $84.46 | -1.03 | -1.2% | $86.49 | $86.49 | $84.00 | 499,700 | |
| $85.49 | -4.44 | -4.9% | $88.83 | $89.18 | $82.70 | 1,294,400 | |
| $89.93 | -4.62 | -4.9% | $94.08 | $95.81 | $85.00 | 1,993,000 | |
| $94.55 | +1.17 | +1.3% | $93.38 | $96.78 | $91.53 | 1,054,900 | |
| $93.38 | -1.58 | -1.7% | $95.75 | $96.00 | $91.75 | 1,185,400 | |
| $94.96 | -2.77 | -2.8% | $98.18 | $98.29 | $94.52 | 1,943,000 | |
| $97.73 | +4.18 | +4.5% | $94.93 | $98.02 | $94.05 | 1,046,900 | |
| $93.55 | +1.35 | +1.5% | $92.70 | $95.46 | $92.19 | 927,000 | |
| $92.20 | -3.73 | -3.9% | $95.14 | $95.81 | $90.41 | 784,600 | |
| $95.93 | +3.55 | +3.8% | $92.56 | $97.48 | $92.55 | 773,800 | |
| $92.38 | +0.73 | +0.8% | $93.40 | $94.29 | $90.48 | 585,300 | |
| $91.65 | +0.15 | +0.2% | $90.21 | $92.29 | $88.07 | 554,600 | |
| $91.50 | -2.81 | -3.0% | $93.59 | $94.85 | $91.23 | 525,000 | |
| $94.31 | +1.80 | +1.9% | $90.06 | $96.44 | $87.68 | 868,300 | |
| $92.51 | +1.52 | +1.7% | $90.06 | $94.00 | $89.38 | 600,500 | |
| $90.99 | -0.64 | -0.7% | $91.72 | $93.69 | $90.12 | 732,600 | |
| $91.63 | -0.48 | -0.5% | $93.05 | $96.20 | $89.88 | 671,700 | |
| $92.11 | -0.51 | -0.6% | $90.78 | $93.20 | $90.27 | 596,200 | |
| $92.62 | +1.47 | +1.6% | $91.00 | $93.88 | $86.00 | 1,292,900 | |
| $91.15 | -5.39 | -5.6% | $95.08 | $95.45 | $91.01 | 589,400 | |
| $96.54 | -2.90 | -2.9% | $98.93 | $99.62 | $96.16 | 614,600 | |
| $99.44 | -2.38 | -2.3% | $101.30 | $102.48 | $98.24 | 526,700 | |
| $101.82 | -0.60 | -0.6% | $104.74 | $106.91 | $100.29 | 1,308,022 | |
| $102.42 | -5.54 | -5.1% | $106.75 | $107.23 | $100.64 | 992,276 | |
| $107.96 | +3.10 | +3.0% | $105.48 | $109.52 | $103.86 | 935,800 | |
| $104.86 | -4.83 | -4.4% | $107.72 | $109.01 | $103.14 | 778,900 | |
| $109.69 | -3.39 | -3.0% | $115.52 | $115.52 | $107.52 | 1,302,900 | |
| $113.08 | +0.42 | +0.4% | $110.27 | $113.31 | $109.55 | 574,900 | |
| $112.66 | +1.62 | +1.5% | $110.22 | $113.04 | $109.09 | 514,900 | |
| $111.04 | +2.92 | +2.7% | $106.02 | $111.37 | $105.10 | 1,047,400 | |
| $108.12 | +0.72 | +0.7% | $108.42 | $108.89 | $103.59 | 719,300 | |
| $107.40 | +2.72 | +2.6% | $106.57 | $109.42 | $104.59 | 945,300 | |
| $104.68 | -0.46 | -0.4% | $107.55 | $107.55 | $102.31 | 812,300 | |
| $105.14 | +6.32 | +6.4% | $96.56 | $105.31 | $95.50 | 872,600 | |
| $98.82 | +0.40 | +0.4% | $99.79 | $100.34 | $97.14 | 308,700 | |
| $98.42 | +1.23 | +1.3% | $96.74 | $99.51 | $96.36 | 717,300 | |
| $97.19 | -0.94 | -1.0% | $98.72 | $99.80 | $95.62 | 639,800 | |
| $98.13 | +3.34 | +3.5% | $96.02 | $98.72 | $94.24 | 621,200 | |
| $94.79 | -1.72 | -1.8% | $94.87 | $96.68 | $90.61 | 807,300 |
- Ticker
- NASDAQ:ORKA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
Latest deck · Oct 26, 2026
Corporate Update (October 2026)
Corporate update · 21 slides
Latest news
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
Oct 26, 2026
Closed $90.33 (+12.7%) on Oct 26, 2026
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
Oct 25, 2026
Closed $90.33 (+12.7%) on Oct 26, 2026
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
Sep 23, 2026
Closed $89.93 (-4.9%) on Sep 23, 2026
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
Sep 9, 2026
Closed $91.65 (+0.2%) on Sep 10, 2026
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
Aug 24, 2026
Closed $101.82 (-0.6%) on Aug 25, 2026
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 10, 2026
Closed $105.14 (+6.4%) on Aug 10, 2026
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
Closed $57.98 (0.0%) on May 28, 2026
Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Closed $63.90 (+1.1%) on May 14, 2026
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
May 6, 2026
Closed $69.79 (+1.2%) on May 6, 2026
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
Apr 28, 2026
Closed $68.10 (-8.0%) on Apr 29, 2026
Decks
Corporate Update (October 2026)
Corporate update · 21 slides · Oct 26, 2026
Investor Presentation (October 2026)
Investor deck · 28 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 30 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026
Oruka Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 85 in all · newest Oct 26, 2026 · oldest 2019
- Decks
- 21 decks · latest Oct 26, 2026
Where Oruka Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ORKA · Home listing · This page | NASDAQ | United States | USD |
| gettex:HQ1 | gettex | Germany | EUR |
| BOATS:ORKA | BOATS | United States | USD |
| LS Exchange:A3DPH3 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DPH3 | Lang & Schwarz | Germany | EUR |
| Tradegate:HQ1 | Tradegate | Germany | EUR |
| Dusseldorf:HQ1 | Dusseldorf | Germany | EUR |
| Munich:HQ1 | Munich | Germany | EUR |
| Frankfurt:HQ1 | Frankfurt | Germany | EUR |
| Stuttgart:HQ1 | Stuttgart | Germany | EUR |
| Hamburg:HQ1 | Hamburg | Germany | EUR |
| Hanover:HQ1 | Hanover | Germany | EUR |
| Xetra:HQ1 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Oruka Therapeutics, Inc.